Brainomix Company
Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.
Investors
%20.jpg)
Headquarters:
Oxford, Oxfordshire, United Kingdom
Industry:
Aging Biomarkers
Employee Number:
9
Estimated Revenue:
$33.16M
Investors Number:
6
Funding Status:
Early Stage Venture
Number Of Exists:
11-50
Last Funding Type:
Series B
Founded Date:
2010-01-01
Total Funding:
35017490
Last Funding Date:
2021-12-16